The Latest Cardiac and Vascular News
EVANSTON, Ill., Sept. 16, 2021 /PRNewswire/ — Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program through the National Institute of Neurological Disorders and Stroke […]
National Institutes of Health grant will support Cardialen’s development of its implantable, low-energy therapy designed to treat atrial fibrillation, a cardiac arrhythmia associated with debilitating shortness of breath, fatigue, pain, and an increased risk of stroke. MINNEAPOLIS–(BUSINESS WIRE)–Cardialen, Inc., has been awarded a $3 million National Institutes of Health (NIH) […]
SAN FRANCISCO, Sept. 16, 2021 /PRNewswire/ — Qardio, Inc. announced today the launch of the first ever fully remote end-to-end RPM service to include cardiac arrhythmia analysis. QardioDirect (Qardio’s all-inclusive service for RPM) now includes ambulatory Cardiac monitoring to help diagnose atrial fibrillation along with a large range of other arrhythmias. Multiple […]
Deep learning platform enables healthcare professionals in France to speed the analysis of electrocardiograms (ECGs), reduce wait times, and improve diagnostic capabilities PARIS and BOSTON, Sept. 16, 2021 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, is collaborating with cardiologists at three medical centers in France to strengthen their cardiology services. Over the […]
Funding round led by Prime Movers Lab ALLSTON, Mass., Sept. 16, 2021 /PRNewswire/ — Elevian, an emerging biotech company developing medicines that restore youthful regenerative capacity with the potential to treat and prevent multiple age-related diseases, today announced that it raised $40 million in an oversubscribed Series A round led by Prime Movers Lab. The […]
WEST CHESTER, Pa., Sept. 16, 2021 /PRNewswire/ — VESTECK, Inc., an early-stage medical device company, is pleased to announce the additional close of funds totaling >$5.2M of Series A financing, which includes conversion of all existing convertible notes. Philadelphia area investors BioAdvance (https://www.bioadvance.com/) and Angel Network (https://angelstarventures.com/) Kennett Square, PA lead these additional investments, joined by several other […]
Company on Schedule to Commence Trial Late This Year VANCOUVER and MINNEAPOLIS, Sept. 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has received FDA approval for the Investigational Device Exemption (“IDE”) regarding the COSIRA-II IDE Clinical Trial. Following multiple discussions with FDA […]
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a therapeutic alternative to people suffering from end-stage biventricular heart failure, today announces that it has received final approval from the Patient Protection […]
PRAIRIE VILLAGE, Kan., Sept. 16, 2021 /PRNewswire/ — Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Joe McConnell as Vice President of Business Operations and Finance and Irina Galkina as Controller. After graduating summa cum laude from Princeton University, McConnell joined the […]
6 Aeson® artificial hearts marketed to date Enrollment of the first cohort of 3 patients in the EFS1 in the USA finalized Cash position of €58 million at June 30, 2021, covering the Company’s activities through to mid-2022 Videoconference with Stéphane Piat today at 5 pm Paris time PARIS–(BUSINESS WIRE)–Regulatory News: […]
